Posted in | News

SUSS MicroTec Announces Sale of Test Systems Division

SUSS MicroTec AG (business address: Schleissheimer Strasse 90, 85748 Garching, Germany; ISIN: DE0007226706), which is listed in the Prime Standard of Deutsche Börse AG, today announced the sale of its Test Systems Division, which is located in Sacka near Dresden, Germany, plus other related assets. The Company was sold to Cascade Microtech, Inc. (NASDAQ: CSCD), a worldwide leader in the precise electrical measurement and test of integrated circuits.

The purchase price for the SUSS MicroTec Test Systems GmbH, which is subject to a post-closing purchase price adjustment, is cash and debt free and consists of a fixed amount and an amount placed in escrow. The fixed component amounts to EUR 4.5 million of which EUR 2.0 million was paid in cash and EUR 2.5 million was paid in shares of Cascade Microtech common stock. In addition, an amount of EUR 2.5 million has been placed in escrow and will be released to the seller upon meeting certain post-sale conditions.

SUSS MicroTec Test Systems is a leading global supplier of measurement and test systems for the semiconductor industry. It employs approximately 120 staff at its Sacka site and its international subsidiaries. In the 2008 fiscal year sales was EUR 25.0 million and EUR 10.6 million for the nine months ended September 30, 2009.

With the divestment of the SUSS MicroTec Test Systems GmbH and the recent acquisition of HamaTech APE, SUSS MicroTec will focus on its core competency of microstructuring for microelectronics applications.

SUSS MicroTec’s comprehensive product portfolio of exposure, cleaning, coating, developing and bonding equipment offers complete high performance solutions for advanced semiconductor packaging and 3D integration as well as the manufacturing of MEMS and LEDs.

Through the acquisition of SUSS MicroTec Test Systems GmbH, who held the second position in the market, Cascade Microtech will strenghten its market leadership position in the semiconductor test probe station market focusing the necessary resources towards developing leading-edge customer solutions to address accelerated growth markets.

“This is a key strategic move for Cascade Microtech which strengthens our product portfolio and leverages our combined resources and competencies,” said F. Paul Carlson, Chairman and CEO, Cascade Microtech, Inc. “We now have the critical mass to focus on the technical challenges our customers have in developing semiconductor processes and designing devices into the next decade. This acquisition enables us to aggressively address emerging applications such as 3D TSV, LED, and MEMS that are on an accelerated growth curve.”

“Divesting the SUSS MicroTec Test Systems GmbH allows us to focus on manufacturing solutions for our high growth core markets of advanced packaging, 3D integration, LED and MEMS’ said Frank P. Averdung, President and CEO of SUSS MicroTec. “Having a broad product range for 3D integration, we anticipate future collaboration with Cascade Microtech in order to address the complex issues in developing and testing 3D through silicon vias (TSVs).”

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    SUSS MicroTec AG. (2019, February 14). SUSS MicroTec Announces Sale of Test Systems Division. AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/news.aspx?newsID=15666.

  • MLA

    SUSS MicroTec AG. "SUSS MicroTec Announces Sale of Test Systems Division". AZoNano. 21 November 2024. <https://www.azonano.com/news.aspx?newsID=15666>.

  • Chicago

    SUSS MicroTec AG. "SUSS MicroTec Announces Sale of Test Systems Division". AZoNano. https://www.azonano.com/news.aspx?newsID=15666. (accessed November 21, 2024).

  • Harvard

    SUSS MicroTec AG. 2019. SUSS MicroTec Announces Sale of Test Systems Division. AZoNano, viewed 21 November 2024, https://www.azonano.com/news.aspx?newsID=15666.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.